|
1
|
Brookmeyer R, Johnson E, Ziegler-Graham K
and Arrighi HM: Forecasting the global burden of Alzheimer's
disease. Alzheimers Dement. 3:186–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selkoe DJ: Alzheimer's disease: Genes,
proteins and therapy. Physiol Rev. 81:741–766. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Epperly T, Dunay MA and Boice JL:
Alzheimer disease: Pharmacologic and nonpharmacologic therapies for
cognitive and functional symptoms. Am Fam Physician. 95:771–778.
2017.PubMed/NCBI
|
|
4
|
Gao LB, Yu XF, Chen Q and Zhou D:
Alzheimer's disease therapeutics: Current and future therapies.
Minerva Med. 107:108–113. 2016.PubMed/NCBI
|
|
5
|
Hardy J and Selkoe DJ: The amyloid
hypothesis of Alzheimer's disease: Progress and problems on the
road to therapeutics. Science. 297:353–356. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng WH, Bastianetto S, Mennicken F, Ma W
and Kar S: Amyloid beta peptide induces tau phosphorylation and
loss of cholinergic neurons in rat primary septal cultures.
Neuroscience. 115:201–211. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi SJ, Kim JK, Kim HK, Harris K, Kim CJ,
Park GG, Park CS and Shin DH: 2,4-Di-tert-butylphenol from sweet
potato protects against oxidative stress in PC12 cells and in mice.
J Med Food. 16:977–983. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Butterfield DA, Castegna A, Lauderback CM
and Drake J: Evidence that amyloid beta-peptide-induced lipid
peroxidation and its sequelae in Alzheimer's disease brain
contribute to neuronal death. Neurobiol Aging. 23:655–664. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Crack PJ, Cimdins K, Ali U, Hertzog PJ and
Iannello RC: Lack of glutathione peroxidase-1 exacerbates
Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm
(Vienna). 113:645–657. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Selkoe DJ: Soluble oligomers of the
amyloid beta-protein impair synaptic plasticity and behavior. Behav
Brain Res. 192:106–113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu JF, Chu SF, Ning N, Yuan YH, Xue W,
Chen NH and Zhang JT: Protective effect of (−)clausenamide against
Abeta-induced neurotoxicity in differentiated PC12 cells. Neurosci
Lett. 483:78–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li G, Ma R, Huang C, Tang Q, Fu Q, Liu H,
Hu B and Xiang J: Protective effect of erythropoietin on
beta-amyloid-induced PC12 cell death through antioxidant
mechanisms. Neurosci Lett. 442:143–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xian YF, Lin ZX, Mao QQ, Ip SP, Su ZR and
Lai XP: Protective effect of isorhynchophylline against
beta-amyloid-induced neurotoxicity in PC12 cells. Cell Mol
Neurobiol. 32:353–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Turunc Bayrakdar E, Uyanikgil Y, Kanit L,
Koylu E and Yalcin A: Nicotinamide treatment reduces the levels of
oxidative stress, apoptosis, and PARP-1 activity in
Aβ(1–42)-induced rat model of Alzheimer's disease. Free Radical
Res. 48:146–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu Y, Dong Y, Tucker D, Wang R, Ahmed ME,
Brann D and Zhang Q: Treadmill exercise exerts neuroprotection and
regulates microglial polarization and oxidative stress in a
streptozotocin-induced rat model of sporadic Alzheimer's disease. J
Alzheimers Dis. 56:1469–1484. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deguchi K, Hayashi T, Nagotani S, Sehara
Y, Zhang H, Tsuchiya A, Ohta Y, Tomiyama K, Morimoto N, Miyazaki M,
et al: Reduction of cerebral infarction in rats by biliverdin
associated with amelioration of oxidative stress. Brain Res.
1188:1–8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dumont M and Beal MF: Neuroprotective
strategies involving ROS in Alzheimer disease. Free Radical Biol
Med. 51:1014–1026. 2011. View Article : Google Scholar
|
|
18
|
Calabrese V, Guagliano E, Sapienza M,
Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C,
Butterfield DA and Stella AG: Redox regulation of cellular stress
response in aging and neurodegenerative disorders: Role of
vitagenes. Neurochem Res. 32:757–773. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Ji X, Zhang J, Shi G, Zhu X and Wang
K: Paeoniflorin attenuates Aβ25-35-induced neurotoxicity in PC12
cells by preventing mitochondrial dysfunction. Folia Neuropathol.
52:285–290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu SL, Chen JC, Li CC, Lo HY, Ho TY and
Hsiang CY: Vanillin improves and prevents trinitrobenzene sulfonic
acid-induced colitis in mice. J Pharmacol Exp Ther. 330:370–376.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JH, Lee HO, Cho YJ, Kim J, Chun J,
Choi J, Lee Y and Jung WH: A vanillin derivative causes
mitochondrial dysfunction and triggers oxidative stress in
Cryptococcus neoformans. PLoS One. 9:e891222014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung HJ, Song YS, Kim K, Lim CJ and Park
EH: Assessment of the anti-angiogenic, anti-inflammatory and
antinociceptive properties of ethyl vanillin. Arch Pharmacal Res.
33:309–316. 2010. View Article : Google Scholar
|
|
23
|
Lirdprapamongkol K, Sakurai H, Kawasaki N,
Choo MK, Saitoh Y, Aozuka Y, Singhirunnusorn P, Ruchirawat S,
Svasti J and Saiki I: Vanillin suppresses in vitro invasion and in
vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci.
25:57–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Makni M, Chtourou Y, Fetoui H, Garoui el
EM, Boudawara T and Zeghal N: Evaluation of the antioxidant,
anti-inflammatory and hepatoprotective properties of vanillin in
carbon tetrachloride-treated rats. Eur J Pharmacol. 668:133–139.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tai A, Sawano T, Yazama F and Ito H:
Evaluation of antioxidant activity of vanillin by using multiple
antioxidant assays. Biochim Biophys Acta. 1810:170–177. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwon J, Kim J, Park S, Khang G, Kang PM
and Lee D: Inflammation-responsive antioxidant nanoparticles based
on a polymeric prodrug of vanillin. Biomacromolecules.
14:1618–1626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dhanalakshmi C, Janakiraman U, Manivasagam
T, Justin Thenmozhi A, Essa MM, Kalandar A, Khan MA and Guillemin
GJ: Vanillin attenuated behavioural impairments, neurochemical
deficts, oxidative stress and apoptosis against rotenone induced
rat model of Parkinson's disease. Neurochem Res. 41:1899–1910.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tai A, Sawano T and Yazama F: Antioxidant
properties of ethyl vanillin in vitro and in vivo. Biosci
Biotechnol Biochem. 75:2346–2350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen XM, Wei M, Zhang HM, Luo CH, Chen YK
and Chen Y: Effect of vanillin and ethyl vanillin on cytochrome
P450 activity in vitro and in vivo. Food Chem Toxicol.
50:1897–1901. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu Y, Sun X, Gong T, He Q and Zhang Z:
antioxidant and antiapoptotic effects of 1,1,1anillin on cytochrome
P450 activity in vitro and in1-one on protecting PC12 cells from
Aβ-induced injury. Mol Pharmaceutics. 11:428–435. 2013. View Article : Google Scholar
|
|
31
|
Kinarivala N, Shah K, Abbruscato TJ and
Trippier PC: Passage variation of PC12 cells results in
inconsistent susceptibility to externally induced apoptosis. ACS
Chem Neurosci. 8:82–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goldsbury C, Whiteman IT, Jeong EV and Lim
YA: Oxidative stress increases levels of endogenous amyloid-β
peptides secreted from primary chick brain neurons. Aging Cell.
7:771–775. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harper JD and Lansbury PT Jr: Models of
amyloid seeding in Alzheimer's disease and scrapie: Mechanistic
truths and physiological consequences of the time-dependent
solubility of amyloid proteins. Annu Rev Biochem. 66:385–407. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jantaratnotai N, Ryu JK, Schwab C, McGeer
PL and McLarnon JG: Comparison of vascular perturbations in an
Aβ-injected animal model and in AD brain. Int J Alzheimers Dis
2011. 2011.
|
|
35
|
Ryu JK and McLarnon JG: A leaky
blood-brain barrier, fibrinogen infiltration and microglial
reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med.
13:2911–2925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beal MF: Oxidatively modified proteins in
aging and disease. Free Radical Biol Med. 32:797–803. 2002.
View Article : Google Scholar
|
|
37
|
Naoi M, Maruyama W, Yi H, Inaba K, Akao Y
and Shamoto-Nagai M: Mitochondria in neurodegenerative disorders:
Regulation of the redox state and death signaling leading to
neuronal death and survival. J Neural Transm (Vienna).
116:1371–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Benedı́ J, Arroyo R, Romero C,
Martı́n-Aragón S and Villar AM: Antioxidant properties and
protective effects of a standardized extract of Hypericum
perforatum on hydrogen peroxide-induced oxidative damage in PC12
cells. Life Sci. 75:1263–1276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen H, Yoshioka H, Kim GS, Jung JE, Okami
N, Sakata H, Maier CM, Narasimhan P, Goeders CE and Chan PH:
Oxidative stress in ischemic brain damage: Mechanisms of cell death
and potential molecular targets for neuroprotection. Antioxid Redox
Signaling. 14:1505–1517. 2011. View Article : Google Scholar
|
|
40
|
Tong Y, Chuan J, Bai L, Shi J, Zhong L,
Duan X and Zhu Y: The protective effect of shikonin on renal
tubular epithelial cell injury induced by high glucose. Biomed
Pharmacother. 98:701–708. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiao X, Liu J, Hu J, Zhu X, Yang H, Wang C
and Zhang Y: Protective effects of protopine on hydrogen
peroxide-induced oxidative injury of PC12 cells via Ca(2+)
antagonism and antioxidant mechanisms. Eur J Pharmacol. 591:21–27.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mueller SG, Trabesinger AH, Boesiger P and
Wieser HG: Brain glutathione levels in patients with epilepsy
measured by in vivo (1)H-MRS. Neurology. 57:1422–1427. 2001.
|
|
43
|
Ghanta S, Banerjee A, Poddar A and
Chattopadhyay S: Oxidative DNA damage preventive activity and
antioxidant potential of Stevia rebaudiana (Bertoni) Bertoni, a
natural sweetener. J Agric Food Chem. 55:10962–10967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee IK, Kang KA, Zhang R, Kim BJ, Kang SS
and Hyun JW: Mitochondria protection of baicalein against oxidative
damage via induction of manganese superoxide dismutase. Environ
Toxicol Pharmacol. 31:233–241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen JX and Yan SD: Pathogenic role of
[correction of mitochondral] amyloid-beta peptide. Expert Rev
Neurother. 7:1517–1525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Iijima T, Mishima T, Tohyama M, Akagawa K
and Iwao Y: Mitochondrial membrane potential and intracellular ATP
content after transient experimental ischemia in the cultured
hippocampal neuron. Neurochem Int. 43:263–269. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Peng HY, Du JR, Zhang GY, Kuang X, Liu YX,
Qian ZM and Wang CY: Neuroprotective effect of Z-ligustilide
against permanent focal ischemic damage in rats. Biol Pharm Bull.
30:309–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tsujimoto Y: Role of Bcl-2 family proteins
in apoptosis: Apoptosomes or mitochondria? Genes Cells. 3:697–707.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tong Y, Bai L, Gong R, Chuan J, Duan X and
Zhu Y: Shikonin protects PC12 cells against β-amyloid
peptide-induced cell injury through antioxidant and antiapoptotic
activities. Sci Rep. 8:262018. View Article : Google Scholar : PubMed/NCBI
|
